In an article in OncLive experts specializing in multiple myeloma mention what they believe to be the top studies presented at the 2021 ASH annual meeting and how their findings have the potential to change clinical practice.
High prevalence of smoldering myeloma observed in nationwide screening study
In an article in CancerTherapyAdvisor.com the iStopMM study and it‘s results are covered. Results from the study were presented at the 2021 American Society of